1. Local injection of bone marrow progenitor cells for the treatment of anal sphincter injury: in-vitro expanded versus minimally-manipulated cells.
- Author
-
Mazzanti B, Lorenzi B, Borghini A, Boieri M, Ballerini L, Saccardi R, Weber E, and Pessina F
- Subjects
- Anal Canal injuries, Animals, Bone Marrow Cells physiology, Disease Models, Animal, Fecal Incontinence physiopathology, Genes, Reporter, Humans, Leukocytes, Mononuclear physiology, Leukocytes, Mononuclear transplantation, Male, Mesenchymal Stem Cells physiology, Muscle Contraction physiology, Rats, Rats, Inbred Lew, Regeneration physiology, Sphincterotomy, Endoscopic, Anal Canal surgery, Bone Marrow Cells cytology, Fecal Incontinence therapy, Leukocytes, Mononuclear cytology, Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells cytology
- Abstract
Background: Anal incontinence is a disabling condition that adversely affects the quality of life of a large number of patients, mainly with anal sphincter lesions. In a previous experimental work, in-vitro expanded bone marrow (BM)-derived mesenchymal stem cells (MSC) were demonstrated to enhance sphincter healing after injury and primary repair in a rat preclinical model. In the present article we investigated whether unexpanded BM mononuclear cells (MNC) may also be effective., Methods: Thirty-two rats, divided into groups, underwent sphincterotomy and repair (SR) with primary suture of anal sphincters plus intrasphincteric injection of saline (CTR), or of in-vitro expanded MSC, or of minimally manipulated MNC; moreover, the fourth group underwent sham operation. At day 30, histologic, morphometric, in-vitro contractility, and functional analysis were performed., Results: Treatment with both MSC and MNC improved muscle regeneration and increased contractile function of anal sphincters after SR compared with CTR (p < 0.05). No significant difference was observed between the two BM stem cell types used. GFP-positive cells (MSC and MNC) remained in the proximity of the lesion site up to 30 days post injection., Conclusions: In the present study we demonstrated in a preclinical model that minimally manipulated BM-MNC were as effective as in-vitro expanded MSC for the recovery of anal sphincter injury followed by primary sphincter repair. These results may serve as a basis for improving clinical applications of stem cell therapy in human anal incontinence treatment.
- Published
- 2016
- Full Text
- View/download PDF